SBI Securities’s IceCure Medical ICCM Stock Holding History

SBI Securities’s Portfolio ICCM Stock Details ICCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$1.1K	Buy	680 +229	+51%	+$642	﹤0.01%	2826
2026 Q2	$2.19K	Buy	+451	New	+$3.26K	﹤0.01%	2526
2026 Q1	–	Hold	0	–	–	–	3941
2025 Q4	–	Hold	0	–	–	–	3973
2025 Q3	–	Hold	0	–	–	–	4134
2025 Q2	–	Hold	0	–	–	–	4096
2025 Q1	–	Hold	0	–	–	–	4044
2024 Q4	–	Hold	0	–	–	–	4059

Other funds holding ICCM

StoneX Group New York $2.75B AUM 24.25% 1-Year Est. Return

Gunderson Capital Management Mt. Pleasant, South Carolina $359M AUM 176.83% 1-Year Est. Return

SBI Securities's ICCM Position: Q3 2026 in Review

SBI Securities increased its IceCure Medical (ICCM) stake by 51% in Q3 2026, buying an estimated $642 and bringing the position to 680 shares worth $1.1K. The position accounts for ﹤0.01% of the portfolio, ranked #2826.

SBI Securities first reported a position in ICCM in Q2 2026 and has held it in 2 quarters since. The position peaked at $2.19K in Q2 2026. 3 funds tracked by Wall St. Rank hold ICCM as of Q3 2026.

SBI Securities held 680 shares of IceCure Medical worth $1.1K as of Q3 2026.
SBI Securities bought 229 IceCure Medical shares in Q3 2026, an estimated $642.
IceCure Medical made up ﹤0.01% of SBI Securities's portfolio in Q3 2026, its #2826 holding.
SBI Securities first reported a position in IceCure Medical in Q2 2026 and has held it in 2 quarters since.
SBI Securities's IceCure Medical position peaked at $2.19K in Q2 2026.
3 funds tracked by Wall St. Rank held IceCure Medical as of Q3 2026.

Based on SBI Securities's 13F filing for Q3 2026, filed 22 Oct 2026.